Chemotherapy in hormone-refractory prostate cancer: Docetaxel with and without VT122.

被引：0
|
作者：
Bhattacharyya, Gouri Shankar
Bascomb, Newell
Malhotra, Hemant
Biswas, Ghanashyam
Bondarde, Shailesh Arjun
机构：
[1] FORTIS Hosp, Kolkata, India
[2] Vicus Therapeut, Morristown, NJ USA
[3] ICON ARO, Jaipur, Rajasthan, India
[4] Sparsh Hosp & Crit Care, Bhubaneswar, India
[5] Shatabdi Super Specialty Hosp, Nasik, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16062
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Weekly docetaxel and epirubicin in treatment of advanced hormone-refractory prostate cancer
    Petrioli, Roberto
    Paolelli, Loretta
    Francini, Edoardo
    Manganelli, Antonio
    Salvestrini, Francesco
    Francini, Guido
    UROLOGY, 2007, 69 (01) : 142 - 146
  • [32] Phase II trial of docetaxel/capecitabine in hormone-refractory prostate cancer
    Kolodziej, Michael
    Neubauer, Marcus A.
    Rousey, Steven R.
    Pluenneke, Robert E.
    Perrine, George
    Mull, Stephanie
    Boehm, Kristi A.
    Ilegbodu, Des
    Asmar, Lina
    CLINICAL GENITOURINARY CANCER, 2006, 5 (02) : 155 - 161
  • [33] Hormone-Refractory prostate cancer
    Rini B.I.
    Small E.J.
    Current Treatment Options in Oncology, 2002, 3 (5) : 437 - 446
  • [34] Hormone-refractory prostate cancer
    Alexandre, I.
    Rixe, O.
    ANNALES D UROLOGIE, 2007, 41 (02) : 47 - 55
  • [35] A phase I study of estramustine, weekly docetaxel, and carboplatin chemotherapy in patients with hormone-refractory prostate cancer
    Oh, WK
    Hagmann, E
    Manola, J
    George, DJ
    Gilligan, TD
    Jacobson, JO
    Smith, MR
    Kaufman, DS
    Kantoff, PW
    CLINICAL CANCER RESEARCH, 2005, 11 (01) : 284 - 289
  • [36] The current role of chemotherapy in metastatic hormone-refractory prostate cancer
    Petrylak, DP
    UROLOGY, 2005, 65 (5A) : 3 - 7
  • [37] Chemotherapy for hormone-refractory prostate cancer: a physician's dilemma
    Tageja, N.
    INTERNAL MEDICINE JOURNAL, 2010, 40 (12) : 864 - 865
  • [38] Chemotherapy for hormone-refractory prostate cancer: Beauty is in the eye of the beholder
    Beer, T
    Raghavan, D
    PROSTATE, 2000, 45 (02): : 184 - 193
  • [39] New standards in the chemotherapy of metastatic hormone-refractory prostate cancer
    Sava, T
    Basso, U
    Porcaro, A
    Cetto, GL
    EXPERT REVIEW OF ANTICANCER THERAPY, 2005, 5 (01) : 53 - 62
  • [40] VEGF assessment and hormone-refractory prostate cancer chemotherapy.
    Cabrespine, Aurelie
    Guy, Laurent
    Chollet, Philippe
    Gachon, Francoise
    Soubrier, Martin
    Cure, Herve
    Penault-Llorca, Frederique
    Kwiatkowski, Fabrice
    Bay, Jacques-Olivier
    CANCER RESEARCH, 2006, 66 (08)
12345